FindMyKOL

Nazir Savji, MD

Basic profile

Morristown Medical Center

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionMorristown, NJ · NortheastSpecialtyInterventional CardiologyFocusCardiology
Active KOLFindMyKOL type: NationalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nazir Savji is a Cardiology physician affiliated with Morristown Medical Center. OpenAlex indexes 63 publications with 4,063 citations (h-index 28).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
63publications

Publications indexed by OpenAlex. Counts exclude supporting files.

4,063citations

Citations across these publications.

28h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
38companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Amgen Inc.
    Program year202530 payments
    $13,558
  • ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
    Program year202513 payments
    $4,883
  • Abbott Laboratories
    Program year202519 payments
    $2,336
All 75 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.3%
    Statin23.9%
    Atorvastatin Calcium48%Rosuvastatin Calcium31%Simvastatin12%Pravastatin Sodium9%
    Part D≥110 patients
    Beta blocker19.2%
    Metoprolol Succinate69%Carvedilol17%Metoprolol Tartrate8%Atenolol7%
    Part D≥121 patients

    + 16 more classes in this area

  • Blood & clotting

    14.8%
    Factor Xa inhibitor8.3%
    Eliquis77%Xarelto23%
    Part D≥52 patients
    P2Y12 inhibitor5.7%
    Clopidogrel82%Brilinta18%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2.2%
    Potassium supplement1.7%
    Potassium Chloride100%
    Part D≥15 patients
    Proton pump inhibitor0.5%
    Pantoprazole Sodium100%
    Part D<11 patients
Where care is delivered (Part B)49.6% facility · 50.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”